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ABSTRACT
Much research focuses on producing maximal
intervention effects. This has generally not resulted in
interventions being rapidly or widely adopted or seen
as feasible given resources, time, and expertise
constraints in the majority of real-world settings. We
present a definition and key characteristics of a
minimum intervention needed to produce change
(MINC). To illustrate use of a MINC condition, we
describe a computer-assisted, interactive minimal
intervention, titled Healthy Habits, used in three
different controlled studies and its effects. This minimal
intervention produced modest to sizable health
behavior and psychosocial improvements, depending
on the intensity of personal contacts, producing larger
effects at longer-term assessments. MINC comparison
conditions could help to advance both health care and
health research, especially comparative effectiveness
research. Policy and funding implications of requiring
an intervention to be demonstrated more effective than





Health care costs in the US were $2.6 trillion in
2010 [1], were 17.4 % [2] of the gross domestic
product in 2009, and are expected to rise to 25 %
[3]. These costs have increased substantially over
the past few decades (http://www.healthcare.gov)
[3]; with the aging of the population, as well as
developments in personalized medicine and en-
hanced diagnostic techniques, likely to increase in
the future.
Unfortunately, numerous effective interventions
are available but not widely or equitably distributed
[4]. Low-income populations and low-resource set-
tings face challenges in finding the time, resources,
and infrastructure supports necessary to produce
successful outcomes from intensive interventions.
Thus, many existing, evidence-based interventions
have low or limited reach among individual patients
and reduced adoption by clinical and public health
settings [5].
A number of interventions have been shown to
be effective, but it is often difficult for consumers,
practitioners, and researchers to know which is
best—and to distinguish any meaningful differences
in outcomes and cost-effectiveness [6]. These con-
cerns have, in part, given rise to comparative
effectiveness research (CER) [6]. The use of aspirin
for cardiovascular disease prevention offers a useful
example. Aspirin is a widely available, minimal,
low-cost, effective intervention. A pragmatic CER
perspective suggests that more expensive, intensive,
or aggressive interventions should be proven to be
more clinically and cost-effective than aspirin to be
recommended for use.
A newer CER strategy for identifying effective
interventions is based on the concept of “minimal
intervention needed to produce change,” or MINC
(Robert Croyle, personal communication, 2010) [7].
In this article, we define MINC as “the minimal or
lowest level of intervention intensity, expertise, and
resources needed to achieve a clinically significant
improvement in a specified outcome for a particular
target population under a particular set of condi-
tions, when delivered by a specified type of staff or
interactive modality.” The goal is to provide an
anchor or standard to help compare different
interventions to determine the relative improve-
ments based on their relative costs. By defining and
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Implications
Practice: MINC conditions have the potential to
produce outcomes equivalent to more intensive
and expensive conditions; to enhance reach,
adoption, implementation, and sustainability;
and reduce costs.
Policy: To help address unsustainable health
care spending increases, funders should consider
if a potential intervention is demonstrably more
cost-effective than a MINC.
Research: Consistent use of MINC conditions
would aid comparisons across studies, provide a
common metric, and aid systematic reviews.
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documenting the MINC in a given content area, it
is possible to identify the least costly, easiest-to-
administer interventions that are most likely to be
disseminated [7].
Several designs have been used to establish the
MINC in different phases of implementation, includ-
ing maintenance. For example, adaptively designed
interventions [7–10] have been used in studies of
mammography adherence, in which intervention
components and intensity change are linked specifi-
cally with patient and care system response [11, 12].
Other designs have included stepped-care approaches
[13] that directly compare more and less intense
intervention components, manipulation of reminders
and encouragement to understand how to motivate
people to engage in the desired behavior, and
variations of follow-up support to understand how to
sustain the behavior change over time [7]. Thus,
finding the MINC presents a promising strategy for
applying the principles of CER.
The purposes of this paper are to define MINC
for practical use (see above), including its key
characteristics; provide applied example applica-
tions; and discuss the potential use and implications
of MINC for health care research and policy.
Key characteristics
Table 1 summarizes key features of MINCs. As can
be seen, a MINC includes a minimal number of
theoretical and empirically based components [14].
A MINC should contain only enough components
to produce meaningful change, as defined above.
Ideally, each intervention component has low inten-
sity and low cost. For example, effective MINCs
incorporate the minimum number of sessions, and
personal contacts or doses needed for success, and
utilize the least trained and least expensive staff (e.g.,
health educators instead of physicians; community
health workers instead of professional staff) that can
effectively implement a program. Finally, as recom-
mended by Rogers [15], to increase widespread
adoption, implementation, and sustainability, MINCs
should have low design and application complexity.
From a Reach, Effectiveness, Adoption, Implementa-
tion, Maintenance [16, 17] or access and scalability
perspective, all of the above features tend to make
MINCsmore broadly adoptable and to increase reach
and quality of implementation, and are theoretically
more likely to be sustained thanmore costly, complex,
and intensive interventions.
A MINC example
To illustrate development and use of MINC inter-
ventions, we describe a MINC chronic disease self-
management intervention used in three controlled
diabetes studies. The computerized intervention,
called variously Healthy Habits or Leap Ahead,
consisted of a health risk appraisal based on recom-
mendations from the US Preventive Services Task
Force [18]. Healthy Habits/Leap Ahead provided a
realistic minimal intervention to enhance usual care
for diabetes self-management. This condition was
initially developed primarily to provide a credible
attention control condition for the automated interac-
tive diabetes self-management interventions. It was
only at the time of our third funded study (Reducing
Distress and Enhancing Effective Management
(REDEEM)) that we began conceptualizing this as a
MINC condition, given some of our findings below.
Targeted to the user's age and gender, it assessed
diabetes-specific and generic preventive activities.
Upon completion of Healthy Habits/Leap Ahead, a
printable report was generated with standardized
recommendations [19], reinforcing diabetes self-man-
agement practices (e.g., checking one's feet, not
smoking, monitoring blood glucose levels, getting flu
shots) and general preventive activities (e.g., wearing a
seat belt, getting a mammogram) [18]. Because
Healthy Habits/Leap Ahead was developed to pro-
vide a realistic but minimal intervention comparison
to more intensive intervention, it did not provide
assistance in the hypothesized key intervention pro-
cesses of goal setting or developing an action plan for
the specific health behaviors under study (diet,
medication adherence, and exercise).
HealthyHabits was created inMacromedia Director
and was deployed as a stand-alone desktop application
for Windows computers. It was developed in English
and translated into Spanish. To maximize ease of use,
keyboard input was required only during the registra-
tion when participants entered name and study ID.
Thereafter, all user inputs were via mouse clicks.
Table 1 | Characteristics and examples of MINCs
Characteristic MINC Status Healthy Habits/Leap Ahead example
MINC
Intensity Low–moderate: Just sufficient for
change
Largely automated; no in-person contact
required; only phone follow-up
Cost and Resources Needed
to Implement
Low: Developed to require few
new resources of setting and
participants
Only require laptop computer in clinic;
no time from primary care staff; minimal
training for research assistant
Theoretical Components Few effective strategies: Use of
common intervention techniques
Assessment; feedback; nonspecific support;
follow-up
Complexity Low: Only what is needed for change Easy to implement
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Participants completed a 19- to 21-item health risk
assessment that included 14 questions related to
their diabetes care, and 5–7 questions related to
general preventive care targeted to their gender and
age. Questions were presented with onscreen text as
well as voiced by a female narrator (Fig. 1). The
narration could be turned on or off at any time. The
program then generated a two-page printout, as
shown in Fig. 2. The first page listed the participant's
positive health habits with a brief description of
each, followed by a listing of areas where the
participant was at risk and ways to address those
risks. The second page listed recommended preven-
tive care procedures grouped by age range, with the
participant's age range highlighted.
Participant data were stored locally in an SQLite
database. If a participant entered a study ID that
was already in the database, the program presented
several options—resuming the program, retaking the
program, or reprinting the printout—to maximize
its ability to be worked into a typical practice's
patient flow. Healthy Habits/Leap Ahead provided
an opportunity for systematically asking patients
about diabetes-related care procedures (e.g., foot
exams, eye exams) and both tailored and targeted
advice on recommended preventive care (e.g.,
alcohol use, vaccines) using minimal patient and
staff time.
Illustrations using Healthy Habits/Leap Ahead
Following is a brief description of three studies in
which the Healthy Habits/Leap Ahead MINC has
been used (Table 2).
Diabetes Health Connection
The Diabetes Health Connection (DHC) study [20]
was a randomized trial that evaluated the effective-
ness of a CD-ROM-based diabetes self-management
intervention relative to Healthy Habits. The more
complex self-management intervention used a com-
puter-assisted behavior-change program to facilitate
healthful, patient-selected dietary and physical ac-
tivity behaviors. All patients, regardless of treatment
condition, completed four study visits facilitated by
a research staff member. Participants in the self-
management condition received a tailored interven-
tion that combined interactive technology with one-
on-one health counseling and telephone follow-up
support between visits, and featured tailored goal
setting, creation of a personalized diabetes self-
management plan, and barriers-based problem solv-
ing. Self-management participants also received 10-
to 15-min follow-up calls 1 week and 1 month later
to review their goals, barriers, and strategies and to
revise their plan (Healthy Habits MINC participants
did not receive these added contacts).
MyPath to Healthy Life
MyPath to Healthy Life (MyPath) was a pragmatic trial
[21] conducted at Kaiser Permanente Colorado with
463 adults with type 2 diabetes (Table 3.) Participants
were randomized to one of three conditions: Healthy
Habits; a web-based diabetes self-management sup-
port program (MyPath) that included online assistance
for setting tailored goals for diet, physical activity, and
medication taking; or the same web-based diabetes
Fig 1 | User interface screens from Healthy Habits
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self-management support program plus additional in-
person support (MyPath-Plus). The online MyPath
programwas similar to the DHCprogram, with added
features for tracking progress on self-management
behaviors, a library of educational materials, and an
“ask an expert” feature.
For those receiving the MyPath intervention, goals
and tailored behavioral action plans were shared
with their providers via electronic health record. All
participants completed three study appointments,
and MyPath/MyPath-Plus participants also received
two follow-up calls and interactive voice response
contact and email prompts to view new features of
the MyPath website. MyPath-Plus participants were
also invited to attend three group seminars. Healthy
Habits participants did not have access to the
MyPath website, calls, or seminars.
Reducing Distress and Enhancing Effective Management
The REDEEM project was a three-arm randomized
comparative trial to reduce diabetes-related distress
Fig 2 | Two-section printout from Healthy Habits
Table 2 | Characteristics of participants assigned to the MINC in three diabetes studies
DHC (n=82)




Mean (SD) or %
Age (years) 63.36 (9.49) 58.58 (9.05) 55.23 (10.88)
Sex (% female) 39.0 % 51.5 % 59.4 %
Years with diagnosis 7.72 (7.63) 7.95 (estimated) 7.60 (6.44)
Education
%≤high school 24.7 % 10.6 % 10.4 %
% Tech school 38.3 % 45.5 % 28.1 %
% College 33.3 % 41.7 % 61.5 %
No. of comorbidities 3.00 (1.86) [of 9] NR 3.55 (2.75) [of 12]
% on insulin 15.2 % 30.0 % 19.8 %
Ethnicity (% White) 77.2 % 70.6 % 35.4 %
% smoke 11.1 % 10.6 % 10.4 %
BMI (kg/m2) 31.61 (7.00) 34.45 (6.29) 34.83 (6.54)
NR Not Reported
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Table 3 | Behavior change results across three diabetes studies on common measures (Healthy Habits/Leap Ahead MINC only)1
DHC (n=82) MyPath (n=132) REDEEM (n=96)
Mean (SD) [F; p] Mean (SD) [F; p] Mean (SD) [F; p]
Food Behav/Habits Kristal score STC score STC score
T1–T2 2.28 (0.39) to 2.21
(0.41) [4.84; 0.031]
2.13 (0.31) to 2.18
(0.27) [6.74; 0.011]
2.07 (0.29) to 2.14 (0.27)
[3.38; 0.07]
T1–T3 2.27 (0.39) to 2.19
(0.39) [5.64; 0.020]
2.14 (0.30) to 2.23
(0.30) [13.10; <0.001]
2.07 (0.29) to 2.21 (0.25)
[11.66; 0.001]
T2–T3 2.21 (0.40) to 2.18
(0.39) [0.59; 0.45]
2.18 (0.26) to 2.23
(0.30) [4.42; 0.038]
2.14 (0.27) to 2.21 (0.25)
[3.73; 0.057]
Fat intake NCI; grams NCI; % NCI; %
T1–T2 30.94 (14.56) to 26.67
(14.54) [7.28; 0.009]
35.10 (4.91) to 35.42
(6.77) [0.30; 0.59]
32.08 (4.21) to 31.25 (2.79)
[4.23; 0.042]
T1–T3 30.60 (15.00) to 31.91
(18.27) [0.33; 0.57]
35.28 (4.92) to 33.98
(4.30) [12.67; 0.001]
32.08 (4.21) to 30.78 (3.50)
[5.77; 0.018]
T2–T3 26.87 (14.91) to 31.69
(17.71) [5.59; 0.021]
35.61 (6.99) to 33.95
(4.12) [5.86; 0.017]
31.25 (2.79) to 30.78 (3.50)
[1.22; 0.27]
Physical activity Freq/week all PA Freq/week all PA Cals/week all PA
T1–T2 30.80 (26.85) to 30.43
(21.88) [0.02; 0.89]
45.48 (51.86) to 41.69
(42.2) [1.53; 0.22]
3,240 (2,384) to 4,030
(3,054) [8.73; 0.004]
T1–T3 30.90 (27.49) to 32.54
(29.65) [0.22; 0.64]
45.18 (47.92) to 43.41
(48.02) [0.22; 0.64]
3,240 (2,384) to 3,464
(2,928) [0.46; 0.50]
T2–T3 31.73 (22.11) to 32.04
(29.66) [0.01; 0.92]
41.04 (39.09) to 40.87
(45.40) [0.00; 0.95]
4,030 (3,054) to 3,464
(2,928) [3.15; 0.08]
Diabetes distress Total distress Total distress
T1–T2 2.88 (1.21) to 2.80
(1.19) [0.86; 0.36]
2.48 (0.85) to 2.27 (0.92)
[8.65; 0.004]
T1–T3 2.87 (1.18) to 2.64
(1.15) [5.50; 0.021]
2.48 (0.95) to 1.98 (0.88)
[34.25; <0.001]
T2–T3 2.80 (1.17) to 2.63
(1.16) [2.73; 0.10]
2.27 (0.92) to 1.98 (0.88)
[8.77; 0.004]
PHQ 9 items 8 items 8 items
T1–T2 5.16 (4.85) to 5.11
(4.67) [0.01; 0.91]
5.77 (4.02) to 5.89
(4.58) [0.16; 0.69]
5.35 (3.84) to 3.54 (4.44)
[17.15; <0.001]
T1–T3 5.03 (4.73) to 5.35
(5.57) [0.40; 0.53]
5.85 (4.26) to 5.26
(4.17) [4.53; 0.036]
5.35 (3.84) to 3.82 (3.91)
[12.61; 0.001]
T2–T3 5.06 (4.72) to 5.41
(5.59) [0.54; 0.47]
5.93 (4.68) to 5.22
(4.13) [5.37; 0.022]
3.54 (4.44) to 3.82 (3.91)
[0.52; 0.47]
Medication adherence Adherence Nonadherence
T1–T2 3.78 (0.29) to 3.80
(0.37) [0.45; 0.50]
1.19 (0.27) to 1.18 (0.35)
[0.25; 0.62]
T1–T3 3.79 (0.29) to 3.84
(0.22) [8.20; 0.005]
1.19 (0.27) to 1.17 (0.23)
[0.49; 0.48]
T2–T3 3.80 (0.39) to 3.85
(0.21) [1.31; 0.26]
1.18 (0.35) to 1.17 (0.23)
[0.02; 0.89]
CIRS total score No T1
T1–T2 1.88 (0.61) to 1.89
(0.64) [0.00; 0.95]
2.12 (0.64) to 2.05 (0.72)
[1.38; 0.24]
T1–T3 1.91 (0.63) to 1.92
(0.67) [0.09; 0.77]
2.12 (0.64) to 2.22 (0.68)
[2.75; 0.10]
T2–T3 2.40 (0.67) to 2.47
(0.55) [1.07; 0.31]
1.89 (0.65) to 1.91
(0.67) [0.12; 0.73]
2.05 (0.72) to 2.22 (0.68)
[5.41; 0.022]
Patient engagement Physician autonomy support PACIC PACIC
T1–T2 5.72 (1.24) to 5.72
(1.36) [0.00; 0.99]
3.20 (0.44) to 3.34
(0.42) [11.28; 0.001]
2.84 (1.03) to 2.81 (1.10)
[0.06; 0.81]
T1–T3 5.71 (1.22) to 5.41
(1.45) [3.86; 0.053]
3.20 (0.44) to 3.40
(0.46) [17.09; <0.001]
2.84 (1.03) to 3.11 (1.11)
[7.36; 0.008]
T2–T3 5.70 (1.39) to 5.43
(1.46) [2.53; 0.12]
3.33 (0.42) to 3.41
(0.44) [2.99; 0.09]
2.81 (1.10) to 3.11 (1.11)
[6.12; 0.015]
Repeated Measures ANOVA; F and p reported for the time effect. T1=baseline; T2=2 months for DHC and 4 months for MyPath and REDEEM;
T3=6 months for DHC and 12 months for My Path and REDEEM
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[22]. The study compared the effectiveness of the
MyPath program with or without Problem-Solving
Therapy, relative to Healthy Habits/Leap Ahead,
the previously described MINC condition. Patients
with self-reported problems with diabetes manage-
ment and moderate to high levels of diabetes
distress (but who were not clinically depressed) were
recruited from five San Francisco Bay Area com-
munity medical group and diabetes education
centers. Leap Ahead patients received the comput-
erized MyPath program and feedback report and,
like intervention participants, a booster session
5 months later, as well as mailed general diabetes
information about healthy living, diet, and physical
activity that coincided with eight live phone calls at
weeks 2, 4, 7, 12, 24, 28, 36, and 48.
Measures—The three studies included many of the
same measures, which helped to facilitate interpreta-
tion of outcomes. Assessment points for the three
studies reported here are time 1=baseline, time 2=
2 months for DHC and 4 months for MyPath and
REDEEM, and time 3=6 months for DHC and
12 months for MyPath and REDEEM. Instruments
for measuring eating behaviors were: a semiquanti-
tative food frequency questionnaire [23] to estimate
percent of calories from saturated fat; the eating
habits score from the seven-item Starting The
Conversation instrument, which measures the fre-
quency of consuming sugary beverages and fast
foods (MyPath, REDEEM) [24]; and estimated fat
intake assessed by the National Cancer Institute's
Percentage Energy from Fat Short Screener [25]. In
all cases, higher scores indicated more healthful
eating habits [24–35]. For physical activity, the
Community Healthy Activities Model Program for
Seniors [32] instrument was used. The Diabetes
Distress Scale was used to measure regimen distress
(MyPath, REDEEM) [29]. Measures of medication
adherence to diabetes, blood pressure, and choles-
terol medications were collected in the MyPath and
REDEEM studies using the Hill-Bone Compliance
Scale [31]. The Chronic Illness Resources Survey
(CIRS) [33] was collected in the MyPath and
REDEEM studies to assess use of supportive
resources across proximal and distal social ecologi-
cal domains. The Patient Assessment of Care for
Improving Chronic Conditions [34] was used to
measure patient engagement in their care in MyPath
and REDEEM, while Physician Autonomy Support
[35] (a measure of the patient's perception of support
for diabetes self-management from his/her health care
team, and patient self-confidence in ability to self-
manage his/her diabetes) was collected in DHC.
Analyses—Descriptive statistics were calculated to
ensure that distributions of the data were appropri-
ate for the tests used. Separately for each of the three
studies, one-way analyses of variance (ANOVA)
were performed to compare baseline characteristics
of participants in the Healthy Habits/Leap Ahead
group to participants assigned to more intensive
intervention conditions. Using data only fromHealthy
Habits/Leap Ahead participants, repeated measures
ANOVA models were conducted separately for each
study to determine the degree to which participants
improved on key outcomes over time.
RESULTS
Participants in these three studies were generally
similar to most community-based adult type 2
diabetes patients. Table 2 presents characteristics of
MINC participants across all studies. In general,
these participants were older, had had diabetes for a
number of years, were overweight or obese, and also
had multiple chronic conditions. There were no
differences among conditions on any of these
baseline measures in any of the three studies.
Behavior change
As can be seen in Table 3 (in italics), Healthy
Habits/Leap Ahead in two studies produced signif-
icant behavior changes in eating patterns and fat
intake reduction, and in one study yielded signifi-
cant physical activity increases and medication-
taking increases.
In general, Healthy Habits/Leap Ahead produced
less short-term behavior change than the more
interactive and intensive tailored conditions in
the DHC and MyPath studies (see Table 3), but
produced equivalent behavior change to the
active interventions in the REDEEM study, when
accompanied by more frequent phone contacts
(data not shown due to complexity and number
of comparisons involved; these comparative outcome
data have been published elsewhere [20–22]).
Healthy Habits/Leap Ahead produced excellent
maintenance results, almost always sustaining initial
gains and, in some cases, continued increases
between the midpoint assessment and the final
follow-up.
Psychosocial Changes
Healthy Habits/Leap Ahead produced relatively
consistent improvements in psychosocial measures,
including diabetes distress (two of two studies),
depression (two of three studies), and patient
engagement (two of three studies). Also, Healthy
Habits/Leap Ahead generally produced psychoso-
cial improvements equivalent to those of the more
complex, tailored conditions (data on this compar-
ison presented elsewhere) [22]. The magnitude of
these improvements was clinically significant and
generally larger than the initial behavior change
improvements.
DISCUSSION
We have provided a MINC definition, discussed key
MINC characteristics, and presented examples from
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three studies using the Healthy Habits/Leap Ahead
minimal intervention. Analyses from these three
randomized diabetes self-management studies con-
sistently indicated that Healthy Habits/Leap Ahead
produced modest to moderate long-term behavior
changes and fairly sizable improvements in psychoso-
cial measures. The more substantial improvements in
psychosocial measures seen especially in the RE-
DEEM trial are clinically significant, and suggest that
a low-intensity intervention with increased follow-up
contact can produce sizable and meaningful improve-
ment compared to initially more intensive and costly
interventions.
Given both conceptual and methodological per-
spectives, and the considerably reduced costs and
complexity of Healthy Habits/Leap Ahead, a strong
argument can be made that, to be recommended or
reimbursed, a new diabetes self-management inter-
vention should be shown to be significantly better
than Healthy Habits/Leap Ahead on these pre-
specified outcomes. In a time of spiraling health
care costs, using a MINC strategy routinely in CER
would allow stakeholders and consumers to know
that a new intervention being tested is worth the
added cost, time, and resources. More frequent and
standard use of the same MINC across different
studies, as demonstrated in this article, along with
harmonized outcome measures [36], would also aid
systematic reviews, comparison across studies, and
judgment of significance of change.
One may ask whether the behavioral medicine
field is sufficiently advanced for this type of
comparison condition. Our answer is that it is. A
strong case can be made, on the basis of both
conservation of limited health care resources and
translation into practice, for such an approach. New
innovations, which are almost always more inten-
sive, expensive, and time consuming than existing
aspirin-like MINC interventions [37], should be able
to demonstrate that their incremental benefits—if
any—are worth the added costs, training, supervi-
sion, and organizational changes required for adop-
tion. Some may feel that requiring a MINC
comparison condition is overly stringent, but we
note that it is congruent with both requirements
and definitions for CER and PCORI [6]. Use of a
MINC vs. usual care comparison condition may
or may not require larger sample sizes to detect
intervention effects, depending on how effective
usual care is and how variable it is across
participating sites. This is because usual care in
some settings is currently evidence-based and in
many others changes over time. If usual care varies
across settings, this will substantially increase the
variance compared to what might be expected from
a standard MINC intervention, and thus could
actually require larger sample sizes to detect a given
effect size.
The greatest potential advantage of MINCs was
not investigated in this article. Because of known
relationships between intervention cost, complexity,
and demand, with reduced adoption by settings,
reach (participation among individuals), implemen-
tation, and sustainability [15], these implementation
outcomes [38] may be the areas in which MINCs
show their strongest effects. Research is needed to
specifically assess the reach, adoption, implementa-
tion, and relative costs of a MINC to other more
intensive conditions.
The MINC intervention described here evolved
only slightly from the initial study to include more
frequent phone follow-up support in the third study,
the REDEEM trial. Although there was not a direct
comparison, the magnitude of improvements ob-
served in REDEEM in a very comparable popula-
tion, especially at follow-up compared to the earlier
studies, suggested that the added time and costs of
the phone follow-up were warranted. As discussed
in the “Introduction” [7–10], there are numerous
approaches to development of MINCs and identifi-
cation of the “essential components”: It seems
premature to recommend one approach or devel-
opment method over others at this time. The
approaches themselves vary in speed, cost, level of
experimental control, and likely acceptability to
stakeholders. Reviewers raised the issue of whether
a MINC should be required to produce a significant
biological outcome. While acknowledging that some
reviewers, study sections, and funders may require
this, we think it overly restrictive to require this as
part of the definition of a MINC. Some areas do not
have agreed-upon biomarkers (e.g., pain, depres-
sion, anxiety); for many conditions, quality of life or
functional outcomes may be more important out-
comes than a biomarker; and it seems inappropriate
to assert that any given class of outcome is always
required across all conditions, questions, and types
of research. It may be that certain areas of research,
e.g., diabetes management, might decide upon
added criteria for a MINC, but even then, there
are many complications concerning which biomark-
er should be required.
This report has limitations. Specifically, we report
data on only one MINC condition and studied
only patients with diabetes. Our sample sizes
precluded subgroup analyses to identify which
patient groups benefited the most and least from
Healthy Habits/Leap Ahead; and some of the
findings, while statistically significant improvements,
were of modest magnitude. Strengths include the
provision of an explicit MINC definition, use of
the same analytic strategy across three controlled
trials, common primary outcome measures across
studies, the consistency of results, and example
applications. We encourage additional research on
characteristics of MINCs, application to other areas,
and use of other outcomes to evaluate MINC
results. Such use has high potential to advance
CER, enhance understanding of outcomes, facilitate
systematic reviews and knowledge syntheses, pro-
duce more efficient interventions with broader reach
and adoption, and reduce costs.
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